Another study that used orthotopic GBM xenograft models demonstrated the feasibility of using an immunoPET probe ([89Zr]Zr-DFO-LEM2/15) on MT1-MMP marker to visualize GBM tumors for diagnostic purposes. This evidence concerns the gene LEMD2 and glioblastoma.